SCHEMBL12801043

SCHEMBL12801043

Brc1ccc2oc3ccc(-n4c5ccccc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)cc3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TSPO P30536 2/20 0.39
▸ GABRP O00591 3/20 0.38
▸ GABRD O14764 3/20 0.38
▸ GABRA1 P14867 3/20 0.38
▸ GABRB1 P18505 3/20 0.38
▸ GABRG2 P18507 3/20 0.38
▸ GABRB3 P28472 3/20 0.38
▸ GABRA5 P31644 3/20 0.38
▸ GABRA3 P34903 3/20 0.38
▸ GABRA2 P47869 3/20 0.38
▸ GABRB2 P47870 3/20 0.38
▸ GABRA4 P48169 3/20 0.38
▸ GABRE P78334 3/20 0.38
▸ GABRA6 Q16445 3/20 0.38
▸ GABRG1 Q8N1C3 3/20 0.38
▸ GABRG3 Q99928 3/20 0.38
▸ GABRQ Q9UN88 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12159648 0.97 SMN1; SMN2 (0.41) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL30445626 0.97 SMN1; SMN2 (0.41) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL29589408 0.97 KDM4E (0.43) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL280347 0.97 KDM4E (0.43) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL14039066 0.94 KDM4E (0.41) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL14868196 0.94 MAPT (0.42) KDM4EGABRPGABRDGABRA1GABRB1
SCHEMBL14039041 0.93 KDM4E (0.40) KDM4EATML3MBTL1TSPOGABRP
SCHEMBL13471423 0.92 PIM1 (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14868195 0.92 PIM1 (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15960477 0.92 TNKS (0.37) KDM4EATML3MBTL1TSPOGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10431750-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2019-10-01 — — US disclosed
US-20190273211-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications UDC IRELAND LTD (IE) 2019-09-05 — — US disclosed
EP-3072943-B1 DIBENZOFURAN/CARBAZOLE-SUBSTITUTED BENZONITRILES IDEMITSU KOSAN CO (JP) 2018-05-02 — — EP disclosed
US-9806270-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2017-10-31 — — US disclosed
US-9806270-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2017-10-31 — — US disclosed
EP-3072943-A1 DIBENZOFURAN/CARBAZOLE-SUBSTITUTED BENZONITRILES Idemitsu Kosan Co., Ltd. (JP) 2016-09-28 — — EP disclosed
EP-3072943-A1 DIBENZOFURAN/CARBAZOLE-SUBSTITUTED BENZONITRILES Idemitsu Kosan Co., Ltd. (JP) 2016-09-28 — — EP disclosed
US-20160190480-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2016-06-30 — — US disclosed
US-20160190480-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2016-06-30 — — US disclosed
EP-3034508-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2016-06-22 — — EP disclosed
EP-2688889-B1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2016-05-18 — — EP disclosed
WO-2012130709-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-10-04 — — WO disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 — — US disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications EIF4A1, ITPR2, ITPR1 KDM4E 1166/4885ATM 3638/4885L3MBTL1 4368/4885
US-10431750-B2 4H-imidazo[1,2-a]imidazoles for electronic applications EIF4A1, ITPR2, ITPR1 KDM4E 1166/4885ATM 3638/4885L3MBTL1 4368/4885
US-20190273211-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications PAH, NISCH, KCNH1 KDM4E 1128/4885ATM 3506/4885L3MBTL1 4627/4885
US-20160190480-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications PAH, NISCH, KCNH1 KDM4E 1128/4885ATM 3506/4885L3MBTL1 4627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback